Financhill
Back

Moleculin Biotech Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
29

MBRX
Moleculin Biotech

Last Price:
2.34
Seasonality Move:
-2.49%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Moleculin Biotech Price Quote

$2.34
-0.10 (-4.1%)
(Updated: November 6, 2024 at 5:55 PM ET)

Moleculin Biotech Key Stats

Sell
29
Moleculin Biotech (MBRX) is a Sell

Day range:
$2.37 - $2.46
52-week range:
$2.12 - $15.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.39%

Volume:
6.7K
Avg. volume:
22.5K
1-year change:
-68.17%
Market cap:
$6.9M
Revenue:
$0
EPS:
$-11.82

How Much Does Moleculin Biotech Make?

Data Unavailable

Is Moleculin Biotech Growing As A Company?

Data Unavailable

Moleculin Biotech Stock Price Performance

What Is Moleculin Biotech 52-Week High & Low?

Moleculin Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Moleculin Biotech?

  • How Much Debt Does Moleculin Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Moleculin Biotech Have?
    Cash and short term investments quarterly total is $10.8M
  • What Is Moleculin Biotech’s Book Value Per Share?
    Book value per share is 6.91

Is Moleculin Biotech Cash Flow Positive?

  • What Is MBRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$25.6M
  • What Is Moleculin Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.4M
  • What Is Moleculin Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Moleculin Biotech Return On Invested Capital

Data Unavailable

Moleculin Biotech Earnings Date & Stock Price

Moleculin Biotech Competitors

  • Who Are Moleculin Biotech's Competitors?
    Below is a list of companies who compete with Moleculin Biotech or are related in some way:
    • Agilent Technologies Inc (A)
    • Cara Therapeutics Inc (CARA)
    • Citius Pharmaceuticals Inc (CTXR)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Seelos Therapeutics Inc (SEEL)

Moleculin Biotech Dividend Yield

Moleculin Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 25.00
Upside from Last Price: 924.59%

Major Shareholders

  • How many MBRX shares are owned by institutional investors?
    398.9K MBRX shares are owned by institutional investors
  • How many MBRX shares are owned by insiders?
    92.1K MBRX shares are owned by insiders